Life ScienceCompany
LEO Pharma M&A Summary
LEO Pharma has acquired 1 company. It has also divested 1 asset.
LEO Pharma’s largest acquisition to date was in 2015, when it acquired Astellas Pharma - Global Dermatology for $761M. It’s largest disclosed sale occurred in 2020, when it sold LEO PDE4 Inhibitor to UNION therapeutics A/S for $200M. LEO Pharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
LEO Pharma Business Overview
Where is LEO Pharma headquartered?
LEO Pharma is headquartered in Ballerup, Denmark.
How many employees does LEO Pharma have?
LEO Pharma has 4,285 employees.
What sector is LEO Pharma in?
LEO Pharma is a life science company.
When was LEO Pharma founded?
LEO Pharma was founded in 1908.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 2
- M&A Advisors 2